Drug Search Results
More Filters [+]

Pizotifen

Alternative Names: pizotifen
Latest Update: 2024-07-15
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: 5-HT2A Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Bangladesh | Brazil | Canada | Chile | Cyprus | Denmark | France | Hong Kong | Iceland | Ireland | Italy | Jordan | Lebanon | Malaysia | New Zealand | Pakistan | Peru | Philippines | Portugal | Saudi Arabia | Slovakia | South Africa | Spain | Sri Lanka | Sweden | Turkey | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pizotifen

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title